Evaluation and stability of the patient acceptable symptom state (PASS) over time in patients with ankylosing spondylitis

Clinical and Experimental Rheumatology

Volumn 30, Issue 1, 2012, Pages 106-109

  Wariaghli, Ghizlane ^a   Allali, Fadoua ^a   Idrissi, Zineb ^a   Berrada, Kenza ^a   Hmamouchi, Ihsane ^a   Abouqal, Redouane ^b   Hajjaj Hassouni, Najia ^a  

^a Hopital El Ayachi   (Morocco)

^b MOHAMMED V UNIVERSITY   (Morocco)

Author keywords

Ankylosing spondylitis; Patient acceptable symptom state

Indexed keywords

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN THRESHOLD; PATIENT ACCEPTABLE SYMPTOM STATE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYNDROME DELINEATION; VISUAL ANALOG SCALE;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SATISFACTION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 84863765352     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. SALAFFI F, STANCATI A, SILVESTRI CA, CIAPETTI A, GRASSI W: Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain 2004; 8: 283-91.
2. JUNIPER EF, GUYATT GH, WILLAN A, GRIFFITH LE: Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47: 81-7.
3. JAESCHKE R, SINGER J, GUYATT GH: Measurement of health status. Ascertaining the minimal clinically important difference. Clin Trials 1989; 10: 407-15.
4. TUBACH F, RAVAUD P, BARON G et al.: Evaluation of clinically relevant changes in patient-reported outcomes in knee and hip osteoarthritis: the minimal clinical imported improvement. Ann Rheum Dis 2005; 64: 29-33.
5. WELLS GA, BOERS M, SHEA B et al.: Minimal disease activity for rheumatoid arthritis: a preliminary definition. J Rheumatol 2005; 32: 2016-24.
6. VAN DER LINDEN S, VALKENBURG HA, CATS A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8.
7. HAGSTRÖMER M, OJA P, SJÖSTRÖM M: The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutr 2006; 9: 755-62.
8. AL-HAZZAA HM: Health-enhancing physical activity among Saudi adults using the International Physical Activity Questionnaire (IPAQ). Public Health Nutr 2007; 10: 59-64.
9. TUBACH F, RAVAUD P, BARON G et al.: Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis 2005; 64: 34-7.
10. MAKSYMOWYCH WP, RICHARDSON R, MALLON C, VAN DER HEIJDE D, BOONEN A: Evaluation and validation of the Patient Acceptable Symptom State (PASS) in patients with Ankylosing Spondylitis. Arthritis Rheum 2007; 57: 133-9.
11. TUBACH F, DOUGADOS M, FALISSARD B, BARON G, LOGEART I, RAVAUD P: Feeling good rather than feeling better matters more to patients. Arthritis Rheum 2006; 55: 526-30.
12. BRAUN J, BRANDT J, LISTING J et al.: Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet 2002; 359: 1187-93.
13. VAN DER HEIJDE D, DIJKMANS B, GEUSENS P et al.: The Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized placebocontrolled trial (ASSERT). Arthritis Rheum 2005; 52: 582-91.
14. BRAUN J, PHAM T, SIEPER J, VAN DER LINDEN S, DOUGADOS M, VAN DER HEIJDE D, and THE ASAS WORKING GROUP: International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003; 62: 817-24.
15. LORRAINE PJ, HAMMOCK RL, BLANTON JM: Predictors of self-rated health status among Texas residents. Prev Chronic Dis 2005; 2: A12.
16. VAN MANEN JG, BINDELS PJ, DEKKER EW et al.: Added value of co-morbidity in predicting health-related quality of life in COPD patients. Respiratory Med 2001; 95: 496-504.
17. BOONEN A: Socioeconomic consequences of ankylosing spondylitis [review]. Clin Exp Rheumatol 2002; 20 (Suppl. 28): S23-6.
18. COHEN JD, CUNIN P, FARRENQ V et al.: Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies. J Rheumatol 2006; 33: 79-81.